Ashton out, Lurker in as CEO at pSivida
pSivida (NSDQ:PSDV) said it named former pharma exectuive Nancy Lurker to replace Paul Ashton as president & CEO, who resigned “to pursue other interests.”
“We are delighted to welcome Nancy Lurker to pSivida. As we move toward the submission of U.S. and E.U. marketing approval applications for Medidur, this is an ideal time to bring on the skill set and experience Nancy possesses. Nancy’s significant experience in building high performing teams, strategic leadership and extensive product commercialization will help us move pSivida to its next stage of development and success. We are grateful to Paul Ashton for his many years of outstanding contribution to pSivida and wish him well in his future endeavors,” chairman David Mazzo said in prepared remarks. Read more
Don’t miss the rest of MassDevice.com’s Personnel Moves – click the page numbers below to read more.